SUTENT

Related by string. Sutent * * Sutent sunitinib malate . SUTENT sunitinib malate . Pfizer Sutent . Sutent sunitinib . sunitinib Sutent . sunitinib Sutent ® . SUTENT ® *

Related by context. All words. (Click for frequent words.) 75 sunitinib malate 73 TORISEL 72 Vandetanib 71 TYKERB 70 vandetanib 70 sorafenib Nexavar 70 axitinib 70 Fludara 69 Dacogen injection 69 PROMACTA 69 YONDELIS 69 pertuzumab 69 CIMZIA TM 69 YERVOY 68 DOXIL 68 Torisel 68 sunitinib 68 TEMODAL 68 enzastaurin 68 Amrubicin 68 ZACTIMA 68 receptor tyrosine kinase inhibitor 68 decitabine 67 Pemetrexed 67 lapatinib Tykerb 67 elotuzumab 67 mRCC 67 relapsed multiple myeloma 67 CIMZIA ™ 67 XGEVA 67 FOLOTYN 67 forodesine 67 VPRIV 67 MYCAMINE 67 Cloretazine 67 TREANDA 67 temsirolimus 67 sorafenib tablets 67 LHRH antagonists 67 CA4P 66 azacitidine 66 Irinotecan 66 docetaxel chemotherapy 66 EOquin TM 66 Boceprevir 66 Afatinib 66 Pradefovir 66 TELCYTA 66 Traficet EN 66 NOXAFIL 66 ISENTRESS 66 Fibrillex TM 66 metastatic CRC 66 obatoclax 66 Dacogen decitabine 66 abiraterone acetate 66 Noxafil 66 Jevtana 66 bevacizumab Avastin 66 BRAF inhibitor 66 Ozarelix 66 cisplatin chemotherapy 66 crizotinib PF # 66 posaconazole 66 Hepatocellular Carcinoma HCC 66 metastatic renal cell carcinoma 66 FTY# 66 phase IIb trial 66 multi kinase inhibitor 66 Taxotere ® 66 HGS# 66 REVLIMID ® 66 regorafenib 66 Ixempra 66 VIDAZA 66 Tarceva TM 66 gefitinib Iressa 66 IRESSA 66 relapsed MM 66 bevacizumab Avastin ® 66 ganetespib 66 placebo controlled clinical 65 tanespimycin 65 SNT MC# 65 elacytarabine 65 Aflibercept 65 romiplostim 65 Everolimus 65 Velcade bortezomib 65 Pazopanib 65 oblimersen 65 ARIMIDEX 65 dasatinib 65 LEUKINE 65 thalidomide Thalomid 65 oral ridaforolimus 65 COPAXONE R 65 MabCampath 65 APTIVUS r 65 Certican 65 Bevacizumab 65 tipranavir 65 EndoTAG TM -1 65 Golimumab 65 FAMPYRA 65 Alemtuzumab 65 Degarelix 65 Proxinium TM 65 SPRYCEL 65 OHR/AVR# 65 IMC A# 65 mapatumumab 65 BAY #-# 65 biologic therapy 65 EGFR inhibitors 65 Neulasta ® 65 Hycamtin 65 ixabepilone 65 pomalidomide 65 tocilizumab 65 IMA# 65 HuMax EGFr 65 HER2 positive metastatic breast 65 PROCHYMAL 65 SUTENT ® 65 REMICADE ® 65 RRMS patients 65 Mylotarg 65 OncoVEX GM CSF 65 Xanafide 65 Plicera 65 alvespimycin 65 refractory CLL 65 MyVax R 65 cilengitide 65 Seliciclib 65 Nexavar ® 65 trabedersen 65 relapsed refractory multiple myeloma 65 Talabostat 65 Halaven 65 ACTEMRA 65 AVASTIN 64 Carfilzomib 64 standard chemotherapy regimen 64 gemcitabine chemotherapy 64 mycophenolate mofetil 64 tyrosine kinase inhibitor 64 CANCIDAS 64 Pertuzumab 64 AEG# 64 Doxil ® 64 trabectedin 64 gastrointestinal stromal tumors GIST 64 KIACTA ™ 64 Dasatinib 64 EOquin 64 rindopepimut 64 paclitaxel Taxol 64 ATL# [001] 64 pegylated liposomal doxorubicin 64 Trastuzumab 64 dosage regimens 64 Raptiva R 64 Sorafenib 64 ponatinib 64 VAPRISOL 64 ofatumumab 64 lumiliximab 64 tesmilifene 64 ularitide 64 REVLIMID R 64 rFVIIa 64 Nexavar sorafenib 64 ZYVOX 64 Raptiva ® 64 docetaxel Taxotere ® 64 BEXXAR 64 cabazitaxel 64 Azedra 64 VELCADE 64 Vectibix monotherapy 64 Phase IIIb clinical 64 INC# 64 COPAXONE ® 64 lintuzumab 64 OMAPRO 64 DAPT 64 Microplasmin 64 FOLFIRI 64 ZOLINZA 64 Genasense ® 64 dasatinib Sprycel ® 64 AGILECT R 64 amrubicin 64 PRADAXA 64 metastatic RCC 64 ELACYT 64 pancreatic NET 64 HQK 64 trastuzumab Herceptin 64 acyclovir Lauriad R 64 Cimzia TM 64 APTIVUS 64 Kepivance 64 Tavocept 64 TELINTRA 64 glufosfamide 64 topotecan 64 Multaq R 64 registrational trial 64 Sym# 64 carboplatin paclitaxel 64 adalimumab Humira 64 Tarceva erlotinib 64 Perifosine 64 low dose cytarabine 64 investigational therapies 64 efalizumab 64 recurrent NSCLC 64 panitumumab 64 iniparib 64 nitazoxanide 64 goserelin 64 CYPHER Stent 64 INCB# [001] 64 MGCD# [001] 64 Advagraf 64 Betaferon ® 64 REVLIMID 64 chlorambucil 64 phase IIb clinical 64 ALGRX 64 adalimumab 63 AZILECT ® 63 cinacalcet 63 ACZ# 63 Zarnestra 63 fulvestrant 63 AEGR 63 assessing T DM1 63 bortezomib Velcade 63 HuLuc# 63 Tasimelteon 63 mTOR inhibitor 63 perifosine 63 PREZISTA r 63 BRIM2 63 biologic DMARD 63 Vidaza 63 MGd 63 Alfimeprase 63 Phase Ib clinical 63 anti angiogenic therapy 63 Neupogen ® 63 ARIXTRA 63 PXD# 63 nilotinib 63 FOLFIRINOX 63 galiximab 63 Reverset 63 Blinatumomab 63 INTELENCE 63 Amigal 63 FOLPI 63 ACTEMRA TM 63 ezogabine 63 Revlimid lenalidomide 63 rilonacept 63 LUX Lung 63 erlotinib Tarceva ® 63 HuMax CD4 63 Azilect ® 63 Eltrombopag 63 Rituximab 63 OPAXIO 63 Catena ® 63 Gemzar ® 63 CCR5 antagonist 63 Fludara ® 63 CBLC# 63 sorafenib 63 dacarbazine 63 Tanespimycin 63 trastuzumab Herceptin ® 63 Herceptin trastuzumab 63 UPLYSO 63 Ceflatonin 63 LymphoStat B belimumab 63 DU #b 63 MAGE A3 ASCI 63 Temsirolimus 63 relapsed SCLC 63 imatinib mesylate Gleevec 63 ofatumumab HuMax CD# 63 INTEGRILIN 63 afatinib 63 Virulizin ® 63 etanercept Enbrel 63 Gleevec imatinib mesylate 63 Aplidin 63 atacicept 63 Angiox R 63 Bezielle 63 Phase IIa trials 63 Bortezomib 63 methylnaltrexone 63 neratinib 63 Glufosfamide 63 lupus nephritis 63 pitavastatin 63 orBec 63 Tyrima 63 Enzastaurin 63 Saforis 63 cetuximab Erbitux 63 luteinizing hormone releasing 63 STELARA 63 eltrombopag 63 nucleoside analog 63 oral FTY# 63 Mipomersen 63 chemoradiotherapy 63 temozolomide 63 ORENCIA R 63 Emselex 63 relapsing MS 63 antiangiogenic therapy 63 infusional 5-FU/LV 63 TYZEKA 63 TYGACIL 63 FOLOTYN ® 63 Lenalidomide 63 radiation sensitizer 63 Bronchitol 63 Phase IIb clinical trials 63 Arranon 63 Zorbtive TM 63 Elitek 63 palonosetron 63 cetuximab Erbitux ® 63 IRX 2 63 recurrent glioblastoma multiforme 63 thymalfasin 63 invasive candidiasis 63 custirsen 63 imatinib Gleevec 63 letrozole Femara 63 polymerase inhibitor 63 rALLy clinical trial 62 terlipressin 62 riociguat 62 cediranib 62 TNF antagonist 62 HuMax CD# 62 paclitaxel Taxol ® 62 MYLOTARG 62 Phase IIb trials 62 AA amyloidosis 62 rNAPc2 62 dacetuzumab 62 Amplimexon 62 Myelodysplastic syndromes MDS 62 bosutinib 62 CCX# 62 AZILECT R 62 Tamibarotene 62 mCRC patients 62 PREZISTA rtv 62 ThermoDox R 62 deforolimus 62 alfa 2a 62 clodronate 62 Eculizumab 62 systemic ALCL 62 Laquinimod 62 Taxotere R 62 cytotoxic chemotherapy 62 Epratuzumab 62 blinatumomab 62 TREDAPTIVE 62 Zolinza 62 vidofludimus 62 Archexin 62 FIRMAGON 62 Maraviroc 62 Leukine 62 REVLIMID lenalidomide 62 vorinostat 62 myelodysplastic syndrome MDS 62 GW# [003] 62 otelixizumab 62 raltegravir 62 GAMMAGARD 62 antiepileptic drug 62 albinterferon alfa 2b 62 lenalidomide Revlimid R 62 TTF Therapy 62 EDEMA3 62 Interferon alfa 62 ASA# 62 Telcyta 62 Ocrelizumab 62 figitumumab 62 Vidofludimus 62 Yondelis ® 62 zalutumumab 62 Keppra ® 62 non metastatic osteosarcoma 62 RG# [001] 62 bendamustine 62 Ophena TM 62 PROLASTIN C 62 Rituxan rituximab 62 standard chemotherapy regimens 62 Telintra 62 metastatic GIST 62 teduglutide 62 talactoferrin 62 LymphoStat B 62 Allovectin 7 ® 62 RhuDex ® 62 OvaRex ® MAb 62 Vectibix 62 vemurafenib 62 glatiramer acetate 62 Pafuramidine 62 Exjade 62 boosted protease inhibitor 62 tafamidis 62 EFAPROXYN 62 erlotinib Tarceva 62 hormone LHRH antagonist 62 cardio renal 62 zanolimumab 62 Ceflatonin R 62 OZURDEX ® 62 Cethromycin 62 plasma kallikrein inhibitor 62 iclaprim 62 panitumumab Vectibix 62 Cimzia ® 62 tipifarnib 62 FASLODEX 62 gemcitabine carboplatin 62 fenofibric acid 62 Onrigin 62 vicriviroc 62 pediatric acute lymphoblastic 62 IV NSCLC 62 FOLFOX4 62 Betaferon R 62 teriflunomide 62 XmAb# 62 Vidaza azacitidine 62 abatacept 62 docetaxel Taxotere R 62 Nuvion 62 partial remissions 62 Firazyr 62 TG# [003] 62 recurrent GBM 62 Aptivus ® 62 ARCOXIA 62 SEBIVO 62 cangrelor 62 DexaSite 62 ADVEXIN 62 Genasense 62 pegfilgrastim 62 eritoran 62 Erlotinib 62 Vfend 62 Ambrisentan 62 heavily pretreated patients 62 dirucotide MBP# 62 Pirfenidone 62 diabetic neuropathic pain 62 mertansine 62 ATACAND 62 Vaprisol 62 STRIDE PD 62 anidulafungin 62 Durezol 62 PHX# 62 SJIA 62 refractory AML 62 JAK inhibitor 62 Panzem R NCD 62 nab paclitaxel 62 refractory gout 62 investigational compound 62 alefacept 62 Virulizin R 62 CTAP# Capsules 62 sargramostim 62 biliary tract cancer 62 imatinib 62 reslizumab 62 Vicinium TM 62 inhibitor RG# 62 Myelodysplastic Syndrome MDS 62 motavizumab 62 HGS ETR2 62 unique alkylating agent 62 lapatinib 62 bevacizumab 62 telbivudine 62 Nanobody 62 Actemra 62 vernakalant 62 CHOP chemotherapy 62 Clevudine 62 splenectomized patients 62 bortezomib Velcade R 62 INTEGRILIN R 62 Gleevec Glivec 62 complete cytogenetic response 62 ximelagatran 62 oxaliplatin Eloxatin 62 TACI Ig 62 Mitoxantrone 62 cetuximab Erbitux R 62 Romiplostim 62 phase IIa clinical 62 MACUGEN 61 brivaracetam 61 XELOX 61 dirucotide 61 IL# PE#QQR 61 Actemra tocilizumab 61 antifungal therapy 61 AMEVIVE 61 visilizumab 61 IFN beta 61 briakinumab 61 Cancidas 61 refractory Hodgkin lymphoma 61 interferon beta therapy 61 CYT# potent vascular disrupting 61 Troxatyl 61 REMINYL ® 61 malignant pleural mesothelioma 61 PSMA ADC 61 Clolar 61 RhuDex 61 belinostat 61 refractory metastatic colorectal cancer 61 Sutent sunitinib 61 Vimpat ® 61 Icatibant 61 CytoFabTM 61 Rasagiline 61 Myocet 61 Eloxatin R 61 ULORIC 61 dose cohorts 61 metastatic HRPC 61 heavily pretreated 61 relapsed ovarian cancer 61 angiogenesis inhibitor 61 Sandostatin LAR Depot 61 APTIVUS ritonavir 61 multiple myeloma MM 61 Aloxi injection 61 sapacitabine 61 talabostat 61 liposomal doxorubicin 61 VFEND 61 palifermin 61 docetaxel Taxotere 61 HoFH 61 EndoTAGTM 1 61 neoadjuvant treatment 61 romidepsin 61 Mycamine 61 Civacir 61 Campath alemtuzumab 61 Arixtra 61 placebo dexamethasone 61 pemetrexed 61 immunomodulatory 61 BENICAR 61 TroVax ® 61 Filgrastim 61 SPRYCEL ® 61 Phase Ib II 61 PF # [001] 61 plus dexamethasone 61 ruxolitinib 61 calcineurin inhibitors 61 SCCHN 61 Doxil 61 dasatinib Sprycel 61 apricitabine 61 hepatocellular carcinoma HCC 61 Hycamtin ® 61 CIMZIA TM certolizumab pegol 61 5-FU/LV 61 vascular disrupting agent 61 relapsing multiple sclerosis 61 deferiprone 61 BARACLUDE ® 61 fludarabine 61 Daclizumab 61 gemcitabine Gemzar 61 indolent NHL 61 Bayer Onyx 61 Pivotal Phase III 61 Etanercept 61 eniluracil 61 olaparib 61 Xelox 61 RezularTM 61 Sapacitabine 61 lenalidomide dexamethasone 61 proteasome inhibitor bortezomib 61 Telatinib 61 non squamous NSCLC 61 antiplatelet therapy 61 Proleukin 61 orphan designation 61 anticancer therapy 61 capecitabine Xeloda 61 Elagolix 61 Cutaneous T 61 Pegintron 61 MEK inhibitor 61 trastuzumab Herceptin R 61 Allovectin 7 61 BARACLUDE R 61 Paraplatin ® 61 ara C 61 TBC# 61 Cladribine Tablets 61 octreotide LAR 61 budesonide foam 61 adult chronic ITP 61 Tekturna HCT 61 Rebif ® 61 HUMIRA 61 ORENCIA ® 61 ancrod 61 Mepact 61 sunitinib Sutent 61 Pfizer Sutent 61 aflibercept 61 TheraSphere 61 aflibercept VEGF Trap 61 Apaziquone 61 ACAPODENE 61 relapsing remitting multiple sclerosis 61 Exherin TM 61 opioid induced constipation 61 oral deforolimus 61 pancreatic neuroendocrine tumors 61 stage IIIB 61 Ranibizumab 61 nucleoside analogues 61 peginterferon 61 Mimpara 61 acute coronary syndromes ACS 61 ADAGIO study 61 bortezomib 61 Aptivus 61 VELCADE melphalan 61 IMiDs 61 bazedoxifene 61 abiraterone 61 Eraxis 61 Pixantrone 61 BENICAR HCT 61 placebo controlled clinical trials 61 Anastrozole 61 xanthine oxidase inhibitor 61 Evoltra 61 Ventavis 61 TRILIPIX 61 SELZENTRY 61 Octreolin 61 dabigatran etexilate 61 Increlex ® 61 sorafenib Nexavar ® 61 T DM1 61 mitoxantrone 61 IV Busulfex 61 Aromasin 61 imipenem 61 KRN# 61 relapsing remitting MS RRMS 61 Gleevec imatinib 61 Gefitinib 61 cytogenetic response 61 antithrombotics 61 MAA submission 61 Loramyc R 61 zoledronic acid 61 CAELYX 61 ProMune 61 BENLYSTA ® 61 Combo Stent 61 TYSABRI natalizumab 61 tasocitinib 61 palliative radiotherapy 61 PegIntron 61 fluvastatin 61 pain palliation 61 DACH platinum 61 oral iron chelator 61 MYDICAR ® 61 myelofibrosis polycythemia vera 61 liposomal formulation 61 ruboxistaurin 61 platinum refractory 61 abatacept Orencia 61 systemic fungal infections 61 PEGINTRON 61 Symadex 61 phase IIb 61 PREOS 61 Twinrix 61 placebo controlled Phase 61 NEVO ™ 61 Vernakalant 61 oral anticoagulant 61 pazopanib 61 Folotyn 61 HGS ETR1 61 exemestane Aromasin 61 noninfectious uveitis 61 Roche Xeloda 61 paclitaxel poliglumex 61 Novartis Zometa 61 ONTAK 61 LAF# 61 metastatic hormone refractory 61 Afinitor 61 pemetrexed Alimta 61 paliperidone ER 61 DAVANAT 61 ThermoDox ® 61 multikinase inhibitor 61 Neuradiab 61 PDE4 inhibitor 61 immunomodulatory therapy 61 tramiprosate Alzhemed TM 61 Nexavar 61 Bonefos 61 Quinamed 61 estramustine 61 oral rivaroxaban 61 Rasilez Tekturna 61 TLK# 61 ALT flares 60 evaluable patients 60 prednisone prednisolone 60 virus HCV infection 60 neoadjuvant therapy 60 Zenvia Phase III 60 bortezomib Velcade ® 60 esophageal candidiasis 60 herpetic keratitis 60 OMP #R# 60 ZOSTAVAX 60 ATL/TV# 60 Erbitux cetuximab 60 Insegia 60 menadione 60 basiliximab 60 depsipeptide 60 edoxaban 60 dexanabinol 60 Meets Primary Endpoint 60 valopicitabine 60 CERVARIX 60 levodopa therapy 60 ISTODAX 60 Ofatumumab 60 pimozide 60 Marqibo 60 Intravenous CP 60 Onco TCS 60 investigational monoclonal antibody 60 nucleotide analogue 60 registrational studies 60 Cytoxan 60 IMGN# 60 oral prodrug 60 opioid induced bowel dysfunction 60 ARIKACE 60 Alocrest 60 Tezampanel 60 Lapatinib 60 azacytidine 60 Cloretazine R VNP#M 60 Targretin 60 Panitumumab 60 Copegus ribavirin 60 alemtuzumab Campath 60 immunosuppressant 60 Cetrorelix 60 AzaSite Plus 60 Abiraterone 60 MERLIN TIMI 60 Avastin bevacizumab 60 Imprime PGG 60 Rilonacept 60 Natalizumab 60 ToGA 60 Alinia 60 Pivotal Clinical Trial 60 Phase Ib 60 Aviptadil 60 EVIZON 60 ERBITUX 60 alkylating agent 60 HRPC 60 Urocidin 60 Vimpat R 60 refractory chronic lymphocytic 60 Voreloxin 60 CINTREDEKIN BESUDOTOX 60 Navelbine ® 60 infliximab Remicade 60 tigecycline 60 prGCD 60 Phase III Clinical Trials 60 cutaneous T cell 60 PEGINTRON TM 60 entinostat 60 CYT# 60 nucleoside analogue 60 JANUVIA 60 adjuvant tamoxifen 60 5FU 60 degarelix 60 IMC #B 60 CCX# B 60 natalizumab 60 GSK# [001] 60 anti TNF alpha 60 Safinamide 60 Telbivudine 60 Valdoxan 60 Panzem R 60 roflumilast 60 TNF antagonists 60 Evoltra ® 60 INCB# [003] 60 metastatic colorectal cancer 60 Denufosol 60 Ridaforolimus 60 myeloproliferative disorders 60 Xcytrin 60 vosaroxin 60 MEK inhibitors 60 BRIM3 60 PARP inhibitor 60 pexiganan 60 Autologous Stem Cell Transplantation 60 mTOR kinase 60 diarrhea predominant irritable 60 Tolvaptan 60 alemtuzumab treated 60 leukemia ALL 60 ARIXTRA R 60 NEUPOGEN 60 antithrombotic therapy 60 IXEMPRA 60 lacosamide 60 alvimopan 60 R roscovitine 60 EXJADE 60 Phase 2b trial 60 oral Xeloda 60 canakinumab 60 PRIALT 60 Marketing Authorisation Application 60 sodium thiosulfate STS 60 PRISTIQ 60 Pivotal Trial 60 trastuzumab DM1 T DM1 60 Pixuvri 60 chronic lymphocytic leukemia CLL 60 RoACTEMRA 60 omacetaxine mepesuccinate 60 pradefovir 60 FUZEON 60 SYMMETRY trial 60 heterozygous FH 60 DEB# 60 REYATAZ R 60 interferon alfa 60 anticancer therapies 60 Fast Track Designation 60 BZL# 60 Gliadel Wafer 60 GvHD 60 SinuNase TM 60 R sorafenib tablets 60 LUMINATE 60 metastatic colorectal 60 Topotecan 60 Diamyd ® 60 entecavir 60 ORENCIA 60 ozarelix 60 Femara letrozole 60 Evoltra TM 60 Zemplar Capsules 60 Removab 60 olmesartan 60 apremilast 60 Trabectedin 60 Ozurdex 60 tolvaptan 60 PegIFN RBV 60 eosinophilic asthma 60 oral salmon calcitonin 60 NUVIGIL 60 baminercept 60 cMET 60 Zytiga 60 Treanda 60 cSSSI 60 Dalbavancin 60 plus gemcitabine 60 TRISENOX 60 liver metastases 60 taxane chemotherapy 60 eprotirome 60 GVAX 60 rALLy 60 lasofoxifene 60 ProSavin 60 phase Ib 60 Nebido 60 recurrent glioblastoma 60 Clolar ® 60 NNRTIs 60 antibody MAb 60 atrasentan 60 renal flares 60 advanced carcinoid 60 RAPTIVA 60 Abbokinase 60 randomized Phase IIb 60 fosbretabulin 60 Apixaban 60 Actilon 60 RLY# 60 maraviroc 60 metastatic malignant 60 pegylated interferon alpha 60 Teysuno 60 plus DOXIL 60 anti leukemic 60 Phenoptin 60 AA Amyloidosis 60 piperacillin tazobactam 60 tamoxifen therapy 60 PEG INTRON 60 refractory CTCL 60 Capecitabine 60 Actimmune ® 60 Phase 2a trial 60 protease inhibitor PI 60 KAPIDEX 60 motesanib 60 Cloretazine ® 60 Oxaliplatin 60 docetaxel prednisone 60 Deforolimus 60 INFERGEN 60 JAK3 60 tyrosine kinase inhibitors 60 pegylated interferon alfa 2b 60 metastatic renal cell 60 chemotherapeutic regimen 60 Vectibix panitumumab 60 Dronedarone 60 Keppra R 60 Phase #b/#a clinical 60 ocrelizumab 60 protein kinase inhibitor 60 Asentar 60 REYATAZ ® 60 cholinesterase inhibitor 60 HDAC Inhibitor 60 Ceflatonin ® 60 Omacetaxine 60 Pimavanserin 60 Camptosar ® 60 Allovectin 7 R 60 relapsed ALL 60 6R BH4 60 Peginterferon alfa 2b 60 bosentan 60 Eribulin

Back to home page